The neuronal isoform of nitric oxide synthase (NOS-1) may be an important regulator of cardiac contractility by modifying calcium release and uptake from sarcoplasmic reticulum. Our working hypothesis was that NOS-1 modulates cardiomyocyte contractility more markedly in rat lines with low versus high congenital aerobic fitness.
Methods and results
Rats performed high-intensity interval treadmill running 5 days per week over 8 weeks; age-matched sedentary rats served as controls. At baseline before the training program, aerobic fitness measured as maximal oxygen uptake was 30% higher, and cardiomyocyte contractility measured as fractional shortening 42% higher in high than in low congenital aerobic fitness rats. Training markedly increased aerobic fitness as well as cardiomyocyte contractility, relaxation and corresponding changes in calcium transient in both lines. Selective inhibition of NOS-1 increased cardiomyocyte contractility (12–43%) and calcium transient amplitude (10–28%), prolonged time to 50% relengthening (13–52%) and time to 50% calcium decay (17–35%), in all groups. Interestingly, NOS-1-inhibition abolished the difference in systolic events between low and high congenital aerobic fitness whereas no such findings occurred in diastolic parameters.
Conclusion
NOS-1-derived nitric oxide production is a modulator of cardiomyocyte contractile performance and calcium handling in rats. It accounts for some of the difference between rats with low versus high congenital aerobic fitness, whereas it contributes little during adaptation to exercise training.
DamyTRatajczakPRobidelEBendallJKOlivieroPBoczkowskiJ, et al. Up-regulation of cardiac nitric oxide synthase 1-derived nitric oxide after myocardial infarction in senescent rats.FASEB J2003; 17:1934–1936.
2.
DamyTRatajczakPShahAMCamorsEMartyIHasenfussG, et al. Increased neuronal nitric oxide synthase-derived NO production in the failing human heart.Lancet2004; 363:1365–1367.
3.
BendallJKDamyTRatajczakPLoyerXMonceauVMartyIMilliezP, et al. Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in beta-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat.Circulation2004; 110:2368–2375.
4.
XuKHusoDLDawsonTBredtDSBeckerLC.Nitric oxide in cardiac sarcoplasmatic reticulum.Natl Acad Sci USA1999; 96:657–662.
5.
EuJPXuLStamlerJSMeissnerG.Regulation of ryanodine receptors by reactive nitrogen species.Biochem Pharmacol1999; 57:1079–1084.
6.
SunJXuLEuJPStamlerJSMeissnerG.Classes of thiols that influence the activity of the skeletal muscle calcium release channel.J Biol Chem2001; 276:15625–15630.
7.
SunJXinCEuJPStamlerJSMeissnerG.Cysteine-3635 is responsible for skeletal muscle ryanodine receptor modulation by NO.Proc Natl Acad Sci U S A2001; 98:11158–11162.
8.
KhanSASkafMWHarrisonRWLeeKMinhasKMKumarA, et al. Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases.Circ Res2003; 92:1322–1329.
9.
KhanSALeeKMinhasKMGonzalezDRRajuSVTejaniAD, et al. Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation-contraction coupling.Proc Natl Acad Sci U S A2004; 101:15944–15948.
10.
SearsCEBryantSMAshleyEALygateCARakovicSWallisHL, et al. Cardiac neuronal nitric oxide synthase isoforms regulates myocardial contraction and calcium handling.Circulation Res2003; 92:52–59.
11.
ZhouLBurnettALHuangPLBeckerLCKuppusamyPKassDA, et al. Lack of nitric oxide synthase depresses ion transporting enzyme function in cardiac muscle.Biochem Biophys Res Commun2002; 294:1030–1035.
12.
MooreRLMuschTIYelamartyRVScadutoRCJrSemanchickAMElenskyM, et al. Chronic exercise alters contractility and morphology of isolated rat cardiac myocytes.Am J Physiol1993; 264 (5 Pt 1):C1180–C1189.
13.
WisløffULoennechenJPFalckGBeisvågVCurrieSSmithGEllingsenØ.Increased contractility and calcium sensitivity in cardiac myocytes isolated from endurance trained rats.Cardiovasc Res2001; 50:495–508.
14.
WisløffULoennechenJPCurrieSSmithGEllingsenØ.Aerobic exercise reduces cardiomyocyte hypertrophy and increases contractility, calcium sensitivity and SERCA-2 in rat after myocardial infarction.Cardiovasc Res2002; 54:162–174.
15.
KemiOJLoennechenJPWisloffUEllingsenO.Intensity-controlled treadmill running in mice: cardiac and skeletal muscle hypertrophy.J Appl Physiol2002; 93:1301–1309.
16.
KemiOJHaramPMWisloffUEllingsenO.Aerobic fitness is associated with cardiomyocyte contractile capacity and endothelial function in exercise training and detraining.Circulation2004; 109:2897–2904.
17.
GiannuzziPTemporelliPLCorraUTavazziL; ELVD-CHF Study Group. Antiremodeling effect of long-term exercise training in patients with stable chronic heart failure: results of the Exercise in Left Ventricular Dysfunction and Chronic Heart Failure (ELVD-CHF) Trial. Circulation2003; 108:554–559.
18.
ZhangL-QZhangX-QMuschTIMooreRLCheungJY.Sprint training restores normal contractility in postinfarction myocytes.J Appl Physiol2000; 89:1099–1105.
19.
ZhangLQZhangX-QNgY-CRothblumLIMuschTIMooreRLCheungJY.Sprint training normalizes calcium transients and SR function in postinfarction rat myocytes.J Appl Physiol2000; 89:38–46.
20.
ReiserPJKlineWOVaghyPL.Induction of neuronal type nitric oxide synthase in skeletal muscle by chronic electrical stimulationin vivo. J Appl Physiol1997; 82:1250–1255.
21.
TidballJGLavergneELauKSSpencerMJStullJTWehlingM.Mechanical loading regulates NOS expression and activity in developing and adult skeletal muscle.Am J Physiol Cell Physiol1998; 275:C260–C266.
22.
RudnickJPuttmannBTeschPAAlknerBSchoserBGSalanovaM, et al. Differential expression of nitric oxide synthases (NOS 1–3) in human skeletal muscle following exercise countermeasure during 12 weeks of bed rest.FASEB J2004; 18:1228–1230.
23.
VassilakopoulosTDivangahiMRallisGKishtaOPetrofBComtoisAHussainSN.Differential cytokine gene expression in the diaphragm in response to strenuous resistive breathing.Am J Respir Crit Care Med2004; 170:154–161.
24.
ZhengHLiYFCornishKGZuckerIHPatelKP.Exercise training improves endogenous nitric oxide mechanisms within the paraventricular nucleus in rats with heart failure.Am J Physiol Heart Circ Physiol2005; 288:H2332–H2341.
25.
DansonEJPatersonDJ.Enhanced neuronal nitric oxide synthase expression is central to cardiac vagal phenotype in exercise-trained mice.J Physiol2003; 546 (Pt 1):225–232.
26.
KochLGBrittonSL.Artificial selection for intrinsic aerobic endurance running capacity in rats.Physiol Genomics2001; 5:45–52.
27.
WisloffUNajjarSMEllingsenOHaramPMSwoapSAl-ShareQ, et al. Cardiovascular risk factors emerge after artificial selection for low aerobic capacity.Science2005; 307:418–420.
28.
WisløffUHelgerudJKemiOJEllingsenO.Intensity-controlled treadmill running in rats: V_rm O_2 and cardiac hypertrophy.Am J Physiol heart Circ Physiol2001; 280:H1301–H1310.
29.
BabuBRGriffithOW.N5-(1-Imino-3-butenyl)-l-ornithine. A neuronal isoform selective mechanism-based inactivator of nitric oxide synthase.J Biol Chem1998; 273:8882–8889.
30.
AshleyEASearsCEBryantSMWatkinsHCCasadeiB.Cardiac nitric oxide synthase 1 regulates basal and beta-adrenergic contractility in murine ventricular myocytes.Circulation2002; 105:3011–3016.
31.
SaavedraWFPaolocciNJohnMEStSkafMWStewartGCXieJS, et al. Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart.Circ Res2002; 90:297–304.
32.
PerezNGGaoWDMarbanE.Novel myofilament calcium-sensitizing property of xanthine oxidase inhibitors.Circ Res1998; 83:423–430.
33.
BerryCEHareJM.Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications.J Physiol2004; 555 (Pt 3):589–606.
34.
FrisardMRavussinE.Energy metabolism and oxidative stress: impact on the metabolic syndrome and the aging process.Endocrine2006; 29:27–32.
35.
DaiLBrookesPSDarley-UsmarVMAndersonPG.Bioenergetics in cardiac hypertrophy: mitochondrial respiration as a pathological target of NO*.Am J Physiol Heart Circ Physiol2001; 281:H2261–H2269.
36.
BorutaiteVBrownGC.Rapid reduction of nitric oxide by mitochondria, and reversible inhibition of mitochondrial respiration by nitric oxide.Biochem J1996; 315 (Pt 1):295–299.
37.
BrownGCMcBrideAGFoxEJMcNaughtKSBorutaiteV.Nitric oxide and oxygen metabolism.Biochem Soc Trans1997; 25:901–904.
38.
ClementiEBrownGCFeelischMMoncadaS.Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione.Proc Natl Acad Sci U S A1998; 95:7631–7636.
39.
KanaiAJPearceLLClemensPRBirderLAVanBibberMMChoiSY, et al. Identification of a neuronal nitric oxide synthase in isolated cardiac mitochondria using electrochemical detection.Proc Natl Acad Sci U S A2001; 98:14126–14131.
40.
FrenchSGiuliviCBalabanRS.Nitric oxide synthase in porcine heart mitochondria: evidence for low physiological activity.Am J Physiol Heart Circ Physiol2001; 280:H2863–H2867
